Abstract
CS teargas is one of the most used tools for crowd-control worldwide. Exposure to CS teargas is known to have consequences on protesters’ health (i.e. eye, skin irritation, respiratory problems), but recent concerns have been raised over its potential gender-specific effects. Indeed, field and clinical observations report cases of menstrual cycle issues among female protesters following high exposure to teargas. The hypothesis of a link between teargas exposure and menstrual cycle issues is plausible from a physiological standpoint, but has not yet been empirically investigated. Using data from a cross-sectional study on Yellow Vests protesters’ health in France, we examined the relationship between exposure to teargas and menstrual cycle issues among female protesters (n = 145). Analyses suggested a positive link between exposure and menstrual cycle perturbations. These results constitute first and preliminary evidence that CS teargas may be linked with menstrual cycle among women, which need corroboration given the importance of this issue. We call for further research on the potential effects of CS teargas on women’s reproductive system.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding to declare
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted in accordance with the 1964 Helsinki declaration and its later amendments, the French legislation on research involving human participants and the 2016 APA Ethical Principles of Psychologists and Code of Conduct. Ethic approval was obtained from Sehir University ethics board (n29-2019).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data underlying our findings can be openly accessed using the following link https://osf.io/k3upf/?view_only=39158ca00ff84a03ad9d3b41691abbba
